These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14644505)

  • 1. Chimeric transcriptional control units for improved liver-specific transgene expression.
    Gehrke S; Jérôme V; Müller R
    Gene; 2003 Dec; 322():137-43. PubMed ID: 14644505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of transcriptional regulatory elements for constructing plasmid vectors.
    Xu ZL; Mizuguchi H; Ishii-Watabe A; Uchida E; Mayumi T; Hayakawa T
    Gene; 2001 Jul; 272(1-2):149-56. PubMed ID: 11470520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo comparative study of chimeric liver-specific promoters.
    Kramer MG; Barajas M; Razquin N; Berraondo P; Rodrigo M; Wu C; Qian C; Fortes P; Prieto J
    Mol Ther; 2003 Mar; 7(3):375-85. PubMed ID: 12668133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An enhancer element 6 kb upstream of the mouse HNF4alpha1 promoter is activated by glucocorticoids and liver-enriched transcription factors.
    Bailly A; Torres-Padilla ME; Tinel AP; Weiss MC
    Nucleic Acids Res; 2001 Sep; 29(17):3495-505. PubMed ID: 11522818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Improvement of transcriptional activity of hTERT promoter by SV40 enhancer].
    Zhang WM; Xue LY; Xu Y; Xing J; Geng X; Wang D; Li YY
    Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):691-3. PubMed ID: 17374218
    [No Abstract]   [Full Text] [Related]  

  • 6. An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas.
    Lam PY; Sia KC; Khong JH; De Geest B; Lim KS; Ho IA; Wang GY; Miao LV; Huynh H; Hui KM
    Mol Ther; 2007 Jun; 15(6):1129-36. PubMed ID: 17426711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
    Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
    J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue specificity of L-pyruvate kinase transgenes results from the combinatorial effect of proximal promoter and distal activator regions.
    Miquerol L; Cluzeaud F; Porteu A; Alexandre Y; Vandewalle A; Kahn A
    Gene Expr; 1996; 5(6):315-30. PubMed ID: 8836739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain.
    Liu BH; Yang Y; Paton JF; Li F; Boulaire J; Kasparov S; Wang S
    Mol Ther; 2006 Dec; 14(6):872-82. PubMed ID: 16904943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol and bile acids regulate cholesterol 7 alpha-hydroxylase expression at the transcriptional level in culture and in transgenic mice.
    Ramirez MI; Karaoglu D; Haro D; Barillas C; Bashirzadeh R; Gil G
    Mol Cell Biol; 1994 Apr; 14(4):2809-21. PubMed ID: 8139578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo.
    Riu E; Grimm D; Huang Z; Kay MA
    Hum Gene Ther; 2005 May; 16(5):558-70. PubMed ID: 15916481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer.
    Guo ZS; Wang LH; Eisensmith RC; Woo SL
    Gene Ther; 1996 Sep; 3(9):802-10. PubMed ID: 8875229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulators prevent transcriptional interference between two promoters in a double gene construct for transgenesis.
    Hasegawa K; Nakatsuji N
    FEBS Lett; 2002 Jun; 520(1-3):47-52. PubMed ID: 12044868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector.
    Argyros O; Wong SP; Niceta M; Waddington SN; Howe SJ; Coutelle C; Miller AD; Harbottle RP
    Gene Ther; 2008 Dec; 15(24):1593-605. PubMed ID: 18633447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte-specific gene expression from integrated lentiviral vectors.
    Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
    J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of gene structures and promoter activities of the chipmunk alpha(1)-antitrypsin-like genes.
    Nakazawa A; Inaba Y; Kamijima A; Kondo N; Ito M; Shiba T; Takamatsu N
    Gene; 2004 Mar; 329():71-9. PubMed ID: 15033530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tissue-specific promoters and microRNA recognition elements on stability of transgene expression after hydrodynamic naked plasmid DNA delivery.
    Wolff LJ; Wolff JA; Sebestyén MG
    Hum Gene Ther; 2009 Apr; 20(4):374-88. PubMed ID: 19199823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IX.
    Schüttrumpf J; Milanov P; Abriss D; Roth S; Tonn T; Seifried E
    Hum Gene Ther; 2011 Jan; 22(1):101-6. PubMed ID: 20677911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNF3beta and GATA-4 transactivate the liver-enriched homeobox gene, Hex.
    Denson LA; McClure MH; Bogue CW; Karpen SJ; Jacobs HC
    Gene; 2000 Apr; 246(1-2):311-20. PubMed ID: 10767553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of viral and mammalian promoters for driving transgene expression in mouse liver.
    Al-Dosari M; Zhang G; Knapp JE; Liu D
    Biochem Biophys Res Commun; 2006 Jan; 339(2):673-8. PubMed ID: 16316630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.